Mariano Pellicano
Overview
Explore the profile of Mariano Pellicano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moscardelli S, Caminiti R, Montonati C, Ceresa F, De Blasio G, Vizzari G, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39408046
: Balloon aortic valvuloplasty (BAV) is currently used as pre-treatment for patients undergoing trans-catheter aortic valve replacement (TAVR) as well as a stand-alone option for subjects with significant contraindications to...
2.
Pellicano M, Montonati C, Pellegrini D, Briguglia D, Giannini F, Coman C, et al.
Can J Cardiol
. 2024 Sep;
40(12):2425-2428.
PMID: 39277074
No abstract available.
3.
Giannini F, Khokhar A, Curio J, Beneduce A, Montonati C, Fabris E, et al.
Can J Cardiol
. 2024 Aug;
40(11):2010-2020.
PMID: 39179204
Background: Coronary access (CA) and percutaneous coronary intervention (PCI) might be challenging after valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) with supra-annular self-expanding valves (SS-TAVs) in surgical aortic valves (SAVs)....
4.
Montonati C, Pellegrini D, DAtri D, Pellicano M, Briguglia D, Giannini F, et al.
Expert Rev Cardiovasc Ther
. 2024 Jul;
22(7):325-337.
PMID: 38970466
Introduction: Over the past two decades, transcatheter aortic valve replacement (TAVR) has expanded its application across all surgical risk levels, including low-risk patients, where, due to longer life expectancy, reducing...
5.
Caminiti R, Vizzari G, Ielasi A, Vetta G, Parlavecchio A, Della Rocca D, et al.
Clin Res Cardiol
. 2024 Jul;
PMID: 38958753
Introduction: Drug-coated balloon (DCB) is an established treatment option for in-stent restenosis and small vessel, de novo, coronary artery disease (CAD). Although the use of this tool is increasing in...
6.
Caminiti R, Ielasi A, Vetta G, Parlavecchio A, Della Rocca D, Pellegrini D, et al.
J Clin Med
. 2024 Jun;
13(12).
PMID: 38930050
The optimal timing to perform percutaneous coronary interventions (PCIs) in patients undergoing transcatheter aortic valve replacement (TAVR) is not well established. In this meta-analysis, we aimed to compare the outcomes...
7.
Ielasi A, Caminiti R, Pellegrini D, Montonati C, Pellicano M, Giannini F, et al.
JACC Cardiovasc Interv
. 2024 Jan;
17(1):101-103.
PMID: 38199746
No abstract available.
8.
Moscarella E, Ielasi A, Montonati C, Pellegrini D, Pellicano M, Briguglia D, et al.
Int J Cardiol
. 2024 Jan;
400:131701.
PMID: 38168557
Background: The new balloon-expandable (BE) Myval transcatheter heart valves (THV) has shown promising early results with low paravalvular leak (PVL) and permanent pacemaker implantation (PPI) rates. Limited data are available...
9.
Buono A, Pellicano M, Regazzoli D, Donahue M, Tedeschi D, Loffi M, et al.
Minerva Cardiol Angiol
. 2023 Sep;
72(2):163-171.
PMID: 37705369
Background: De novo diffuse coronary artery disease (CAD) is a challenging scenario in interventional cardiology with limited treatment option, beside stent implantation. In this context, a hybrid approach, combining the...
10.
Ielasi A, Buono A, Pellicano M, Briguglia D, Uccello G, Cortese B, et al.
Minerva Cardiol Angiol
. 2023 Aug;
72(2):212-214.
PMID: 37539676
No abstract available.